Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 181 AL 195

Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors

Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Andronie-Cioara FL, Toma MM, Bungau S, Bumbu AG.

Molecules. 2021 Jun 18;26(12):3724. doi: 10.3390/molecules26123724.

Metal-Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin

Prasad S, DuBourdieu D, Srivastava A, Kumar P, Lall R.

Int J Mol Sci. 2021 Jun 30;22(13):7094. doi: 10.3390/ijms22137094.

Nutraceutical and Probiotic Approaches to Examine Molecular Interactions of the Amyloid Precursor Protein APP in Drosophila Models of Alzheimer's Disease

Jalali D, Guevarra JA, Martinez L, Hung L, Vonhoff FJ.

Int J Mol Sci. 2021 Jun 29;22(13):7022. doi: 10.3390/ijms22137022.

Mesenchymal stem cell therapies for Alzheimer's disease: preclinical studies

Zhao X, Li D, Zhang L, Niu Y, Wang W, Niu B.

Metab Brain Dis. 2021 Oct;36(7):1687-1695. doi: 10.1007/s11011-021-00777-6. Epub 2021 Jul 2.

Social Network Analysis of Alzheimer's Teams: A Clinical Review and Applications in Psychiatry to Explore Interprofessional Care

Lazzari C, Kotera Y, Green P, Rabottini M.

Curr Alzheimer Res. 2021;18(5):380-398. doi: 10.2174/1567205018666210701161449.

Gene and cell therapy for the nucleus basalis of Meynert with NGF in Alzheimer's disease

Eriksdotter M, Mitra S.

Handb Clin Neurol. 2021;179:219-229. doi: 10.1016/B978-0-12-819975-6.00012-1.

Aducanumab for Alzheimer's disease?

Walsh S, Merrick R, Milne R, Brayne C.

BMJ. 2021 Jul 5;374:n1682. doi: 10.1136/bmj.n1682.

Clinical Efficacy, Drug Safety, and Surrogate Endpoints: Has Aducanumab Met All of Its Expectations?

Hershey LA, Tarawneh R.

Neurology. 2021 Sep 14;97(11):517-518. doi: 10.1212/WNL.0000000000012453. Epub 2021 Jul 7.

A contentious FDA ruling for Alzheimer's disease

The Lancet Neurology.

Lancet Neurol. 2021 Aug;20(8):585. doi: 10.1016/S1474-4422(21)00215-5. Epub 2021 Jul 5.

Therapeutic potential of ferulic acid and its derivatives in Alzheimer's disease-A systematic review

Phadke AV, Tayade AA, Khambete MP.

Chem Biol Drug Des. 2021 Nov;98(5):713-721. doi: 10.1111/cbdd.13922. Epub 2021 Jul 16.

Neurostimulation for cognitive enhancement in Alzheimer's disease (the NICE-AD study): a randomized clinical trial

Gulley E, Verghese J, Blumen HM, Ayers E, Wang C, Portenoy RK, Zwerling JL, Weiss E, Knotkova H.

Neurodegener Dis Manag. 2021 Aug;11(4):277-288. doi: 10.2217/nmt-2020-0061. Epub 2021 Jul 9.

An update on Alzheimer's disease: Immunotherapeutic agents, stem cell therapy and gene editing

Patwardhan AG, Belemkar S.

Life Sci. 2021 Oct 1;282:119790. doi: 10.1016/j.lfs.2021.119790. Epub 2021 Jul 8.

NM101 Phase III study of NE3107 in Alzheimer's disease: rationale, design and therapeutic modulation of neuroinflammation and insulin resistance

Reading CL, Ahlem CN, Murphy MF.

Neurodegener Dis Manag. 2021 Aug;11(4):289-298. doi: 10.2217/nmt-2021-0022. Epub 2021 Jul 12.

The Current State of Pharma and the FDA: Approval of a Dementia Drug as a Case in Point

Eiser AR.

Am J Med. 2021 Dec;134(12):1442-1443. doi: 10.1016/j.amjmed.2021.06.014. Epub 2021 Jul 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias